Search Options Stock News and Analysis from Schaeffer's

BREAKING NEWS: Tech Trims Gains, Strong Bank Earnings Send Dow to Fresh Peak

About Us
Market News
Premium
Options 101
Deals
Log-In
Search

>> Our latest Market Mashup Podcast unpacks earnings trends with Estimize’s Founder and CEO Leigh Drogen. <<

content-search-index Tag: NASDAQ-ARWR NASDAQ-ARWR 4 SEARCH RESULTS FOR: "Tag: NASDAQ-ARWR"

REFINE YOUR SEARCH

REFINE YOUR SEARCH:

ARTICLES/BLOGS

2018(4)

CATEGORIES

Analyst Update(1)

Buzz Stocks(1)

Intraday Option Activity(1)

Options Recommendations(1)

Quantitative Analysis(1)

Stock Market News(1)

Stocks On the Move(1)

Unusual Trading Activity(1)

Options Hedges in Demand on Volatile Arrowhead Pharmaceuticals Stock

https://www.schaeffersresearch.com/content/options/2018/05/15/options-hedges-in-demand-on-volatile-arrowhead-pharmaceuticals-stock

5/15/2018 3:10 PM

Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) gapped to a three-year high of $10.10 yesterday, before swinging to a loss. Today, the shares have resumed their longer-term uptrend, adding 2.3% to trade a...

2 Upgraded Drug Stocks Squeezing Shorts

https://www.schaeffersresearch.com/content/news/2018/05/09/2-upgraded-drug-stocks-squeezing-shorts

5/9/2018 10:21 AM

T2 Biosystems Inc (NASDAQ:TTOO) was upgraded to "buy" from "neutral" at Janney, after the sepsis specialist reported first-quarter revenue of $2.3 million -- well above the consensus estimate of $1.4 ...

Analyst Notes Lift ARWR, DVAX Stocks; ESPR Jumps On Drug Data

https://www.schaeffersresearch.com/content/news/2018/03/27/analyst-notes-lift-arwr-dvax-stocks-espr-jumps-on-drug-data

3/27/2018 2:03 PM

The Dow is holding higher this afternoon thanks to a strong move from GE stock. Three other names making notable moves today are drug stocks Esperion Therapeutics Inc (NASDAQ:ESPR), Arrowhead Pharm...

Buy Calls On These 2 Biotech Stocks

https://www.schaeffersresearch.com/content/analysis/2018/03/13/buy-calls-on-these-2-biotech-stocks

3/13/2018 3:03 PM

Pharmaceutical stocks went on a tear recently, with the iShares Nasdaq Biotechnology ETF (IBB) fresh off a seven-day winning streak -- its longest series of consecutive gains since March 2015. While...

PEOPLE ALSO SEARCH FOR